Travel Info

The National Ataxia Foundation (NAF), the Friedreich’s Ataxia Research Alliance (FARA), and Ataxia UK are pleased to announce the rescheduled date for the inaugural International Congress for Ataxia Research (ICAR) to be held at Renaissance Dallas Addison Hotel in Dallas, Texas, USA. Please save the date for November 1-4, 2022.
Abstract submission and registration are open

Abstract Submission schedule

June 13th, 2022: Abstract Submission Deadline (11:59pm ET)
August 15th, 2022: Abstract Acceptance Announced

This Congress will combine the best of our organizations’ popular research meetings, including NAF’s Ataxia Investigators Meeting (AIM) and the International Ataxia Research Conference (IARC), co-led by FARA, Ataxia UK, GoFAR, and other partner organizations. ICAR 2022 will include plenary sessions, poster sessions, breakouts and workshops. Featured topics include: gene discovery, disease mechanisms, cerebellar non-motor circuits and functions, emerging and existing therapeutics, biomarkers and late breaking research. ICAR will also feature workshops with practical demonstrations, discussions on challenges of new and established technologies, and sessions specifically designed by and for junior investigators.

Click HERE to view the Provisional Program.

On November 4th-5th, after ICAR, there will be the Conference of the Ataxia Global Initiative (AGI). The AGI conference brings together academia, industry as well as patient advocacy organizations and will focus on trial-readiness for ataxias. Delegates may be interested in attending both conferences as the programs are distinct and complimentary to each other. For more information, to submit an abstract and to register visit the AGI website: https://ataxia-global-initiative.net/events/ataxia-global-conference-2022/

Please note that delegates can submit abstracts to both ICAR and AGI conferences but will likely not be invited to give the same oral presentations at both.

ICAR Scientific Steering Committee

Lauren Moore, PhD, National Ataxia Foundation
Stefan Pulst, MD, Dr. med., University of Utah - Co-Chair
Massimo Pandolfo, MD, F.A.A.N., F.E.A.N., McGill University – CO-Chair
Roy Sillitoe, PhD, Baylor College of Medicine
Andrea Németh, DPhil, FRCP, University of Oxford
Deborah Hall, MD, PhD, Rush University
Ian Harding, PhD, Monash University
Sue Hagen, National Ataxia Foundation
Julie Greenfield, PhD, Ataxia UK
Elisabetta Soragni, PhD, Friedreich’s Ataxia Research Alliance

Trainee Organizing Committee

Gabriela Bolzan, MD, PhD, Universidade Federal do Rio Grande do Sul, Brazil
Ronald Buijsen, PhD, Leiden University Medical Center, Netherlands
Mohamed Elsaey, Dr. rer. nat., Suez Canal University, Egypt
Elisabetta Indelicato, MD, PhD, Medical University of Innsbruck, Austria
Layne Rodden, PhD, Children’s Hospital of Philadelphia, USA
Celeste Suart, PhD Candidate, McMaster University, Canada

COVID-19 is a rapidly evolving situation and the ICAR Planning Committee is monitoring the situation closely. At present, we are still planning and preparing for an in-person congress with a live stream of main stage presentations. However, we recommend that attendees do not book non-refundable travel.